1
|
Sampogna G, Luciano M, Di Vincenzo M, Andriola I, D'Ambrosio E, Amore M, Serafini G, Rossi A, Carmassi C, Dell'Osso L, Di Lorenzo G, Siracusano A, Rossi R, Fiorillo A. The Complex Interplay Between Physical Activity and Recovery Styles in Patients With Severe Mental Disorders in a Real-World Multicentric Study. Front Psychiatry 2022; 13:945650. [PMID: 35898630 PMCID: PMC9309609 DOI: 10.3389/fpsyt.2022.945650] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Accepted: 05/31/2022] [Indexed: 11/13/2022] Open
Abstract
Compared with the general population, people with severe mental disorders have significantly worse physical health and a higher mortality rate, which is partially due to the adoption of unhealthy lifestyle behaviors, such as heavy smoking, use of alcohol or illicit drugs, unbalanced diet, and physical inactivity. These unhealthy behaviors may also play a significant role in the personal and functional recovery of patients with severe mental disorders, although this relationship has been rarely investigated in methodologically robust studies. In this paper, we aim to: a) describe the levels of physical activity and recovery style in a sample of patients with severe mental disorders; b) identify the clinical, social, and illness-related factors that predict the likelihood of patients performing physical activity. The global sample consists of 401 patients, with a main psychiatric diagnosis of bipolar disorder (43.4%, N = 174), psychosis spectrum disorder (29.7%; N = 119), or major depression (26.9%; N = 118). 29.4% (N = 119) of patients reported performing physical activity regularly, most frequently walking (52.1%, N = 62), going to the gym (21.8%, N = 26), and running (10.9%, N = 13). Only 15 patients (3.7%) performed at least 75 min of vigorous physical activity per week. 46.8% of patients adopted sealing over as a recovery style and 37.9% used a mixed style toward integration. Recovery style is influenced by gender (p < 0.05) and age (p < 0.05). The probability to practice regular physical activity is higher in patients with metabolic syndrome (Odds Ratio - OR: 2.1; Confidence Interval - CI 95%: 1.2-3.5; p < 0.050), and significantly lower in those with higher levels of anxiety/depressive symptoms (OR: 0.877; CI 95%: 0.771-0.998; p < 0.01). Globally, patients with severe mental disorders report low levels of physical activities, which are associated with poor recovery styles. Psychoeducational interventions aimed at increasing patients' motivation to adopt healthy lifestyle behaviors and modifying recovery styles may improve the physical health of people with severe mental disorders thus reducing the mortality rates.
Collapse
Affiliation(s)
- Gaia Sampogna
- Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy
| | - Mario Luciano
- Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy
| | - Matteo Di Vincenzo
- Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy
| | - Ileana Andriola
- Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy
| | - Enrico D'Ambrosio
- Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy
| | - Mario Amore
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy
| | - Gianluca Serafini
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy
| | - Alessandro Rossi
- Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy
| | - Claudia Carmassi
- Psychiatric Unit, Department of Clinical and Experimental Medicine, AOUP, University of Pisa, Pisa, Italy
| | - Liliana Dell'Osso
- Psychiatric Unit, Department of Clinical and Experimental Medicine, AOUP, University of Pisa, Pisa, Italy
| | - Giorgio Di Lorenzo
- Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
| | - Alberto Siracusano
- Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
| | - Rodolfo Rossi
- Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy.,Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
| | - Andrea Fiorillo
- Department of Psychiatry, University of Campania "L. Vanvitelli", Naples, Italy
| | | |
Collapse
|
2
|
Callegari C, Ielmini M, Caselli I, Lucca G, Isella C, Diurni M, Pettenon F, Poloni N. Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study. PSYCHOPHARMACOLOGY BULLETIN 2019; 49:28-43. [PMID: 30858637 PMCID: PMC6386432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
BACKGROUND The impact of menopause is a consequence of social, physical and mental changes; hormonal changes play an important role in inducing an increased risk of developing depressive symptoms. It is essential to treat mood and vasomotor symptoms and to prevent their onset to promote an improvement in the quality of life, both in terms of clinical and psychological conditions. OBJECTIVE This observational study aims to compare paroxetine and vortioxetine in a sample of patients affected by postmenopausal depression attending the Anxiety and Depression Clinic in terms of: efficacy in determining clinical remission (HDRS ≤ 7) and tolerability; improvement of autonomic and cognitive symptoms. METHODS 39 female outpatients with a diagnosis of Postmenopausal Depression (according to DSM-5 criteria) were evaluated as the routine clinical practice through the following scales: Hamilton Depression Rating Scale (HDRS); Menopause Rating Scale (MRS); Montreal Cognitive Assessment (MoCA); Antidepressant Side-Effect Checklist (ASEC); data from/of baseline, after 8 weeks and 12 weeks were recorded. RESULTS Both antidepressants resulted to be effective in clinical remission (HDRS ≤ 7) without statistical differences between the two groups (p = 0.3), although paroxetine showed a faster remission than vortioxetine (p = 0.01). Autonomic symptoms showed a higher improvement in the vortioxetine group (p = 0.002). Paroxetine group referred insomnia and sexual problems while patients taking vortioxetine referred diarrhoea and palpitations. Data show a superiority of cognitive performance in the Paroxetine group (p = 0.005), contrary to what stated in literature. CONCLUSIONS Data are related to a small sample retrospectively assessed trough a 6-month observation period. Thus, the preliminary results need further research to be confirmed.
Collapse
Affiliation(s)
- Camilla Callegari
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Marta Ielmini
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Ivano Caselli
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Giulia Lucca
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Celeste Isella
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Marcello Diurni
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Fabiana Pettenon
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| | - Nicola Poloni
- Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Ielmini, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Caselli, MD, PhD Student, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Lucca, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Isella, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Diurni, MD, PhD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Pettenon, MD, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy. Poloni, MD, PhD, Researcher, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy
| |
Collapse
|